C/EBPα short-activating RNA suppresses metastasis of hepatocellular carcinoma through inhibiting EGFR/β-catenin signaling mediated EMT

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Huan, Hongbo ^a   Wen, Xudong ^a   Chen, Xuejiao ^a   Wu, Lili ^a   Liu, Weihui ^b   Habib, Nagy A ^c   Bie, Ping ^a   Xia, Feng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA CATENIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; EPIDERMAL GROWTH FACTOR RECEPTOR; RNA;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HEPATOCELLULAR CARCINOMA CELL LINE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; NEOPLASM METASTASIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA; SIGNAL TRANSDUCTION;

EID: 84963537517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153117     Document Type: Article

References (39)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87-108. doi: 10.3322/caac.21262 PMID: 25651787
2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2): 115-132. doi: 10.3322/caac.21338 PMID: 26808342
3. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379(9822): 1245-1255. doi: 10.1016/S0140-6736(11)61347-0 PMID: 22353262
4. Forner A, Bruix J. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 2012; 13 (8): 750-751. doi: 10.1016/S1470-2045(12)70271-1 PMID: 22738800
5. Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, et al. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapenta-plegic 2 and 4. Hepatology. 2015; 62(3): 801-815. doi: 10.1002/hep.27887 PMID: 25953743
6. Zeng C, Zhang Y, Park SC, Eun JR, Nguyen NT, Tschudy-Seney B, et al. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates. Stem Cells. 2015; 24(21): 2467-2478.
7. Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, et al. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats. J Cancer Res Clin Oncol. 2015; 141(10): 1767-1778. doi: 10.1007/s00432-015-1943-0 PMID: 25724413
8. Muller C, Bremer A, Schreiber S, Eichwald S, Calkhoven CF. Nucleolar retention of a translational C/EBPalpha isoform stimulates rDNA transcription and cell size. EMBO J. 2010; 29(5): 897-909. doi: 10.1038/emboj.2009.404 PMID: 20075868
9. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, et al. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res. 2007; 67(10): 4657-4664. PMID: 17510391
10. Shi DB, Wang YW, Xing AY, Gao JW, Zhang H, Guo XY, et al. C/EBPalpha-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer. Cancer Lett. 2015; 369(2): 376-385. doi: 10.1016/j.canlet.2015.08.029 PMID: 26404754
11. Ming J, Zhou Y, Du J, Fan S, Pan B, Wang Y, et al. miR-381 suppresses C/EBPodependent Cx43 expression in breast cancer cells. Biosci Rep. 2015; 35(6). pii: e00266. doi: 10.1042/BSR20150167 PMID: 26450928
12. Lu GD, Ang YH, Zhou J, Tamilarasi J, Yan B, Lim YC, et al. CCAAT/enhancer binding protein alpha predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma. Hepatology. 2015; 61(3): 965-978. doi: 10.1002/hep.27593 PMID: 25363290
13. Xue M, Li X, Chen W. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein alpha by hypoxia inducible factor-1alpha in bladder transitional carcinoma cells. Mol Med Rep. 2015; 12(2): 2121-2127. doi: 10.3892/mmr.2015.3563 PMID: 25824695
14. Reebye V, Saetrom P, Mintz PJ, Huang KW, Swiderski P, Peng L, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology. 2014; 59(1): 216-227. doi: 10.1002/hep.26669 PMID: 23929703
15. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6): 1420-1428. doi: 10.1172/JCI39104 PMID: 19487818
16. Rhee KJ, Lee JI, Eom YW. Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression. Int J Mol Sci. 2015; 16(12): 30015-30033. doi: 10.3390/ijms161226215 PMID: 26694366
17. Claperon A, Mergey M, Nguyen Ho-Bouldoires TH, Vignjevic D, Wendum D, Chrétien Y, et al. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelialmesenchymal transition. J Hepatol. 2014; 61(2): 325-332. doi: 10.1016/j.jhep.2014.03.033 PMID: 24704591
18. Qi J, Yu Y, Akilli Ozturk O, Holland JD, Besser D, Fritzmann J, et al. New Wnt/beta-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals. Gut. 2015; pii: gutjnl-2014-307900. doi: 10.1136/gutjnl-2014-307900
19. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94(2): 153-156. PMID: 11668491
20. Gao Y, Chen G, Zeng Y, Zeng J, Lin M, Liu X, et al. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma. Tumour Biol. 2015; 36(10): 7409-7422. doi: 10.1007/s13277-015-3408-0 PMID: 25900874
21. Liu YN, Kang BB, Chen JH. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells. Oncogene. 2004; 23(1): 278-288. PMID: 14712233
22. Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014; 49(4): 589-593. doi: 10.1007/s00535-014-0932-4 PMID: 24531873
23. Reebye V, Saetrom P, Mintz PJ, Rossi JJ, Kasahara N, Nteliopoulos G, et al. A Short-activating RNA Oligonucleotide Targeting the Islet beta-cell Transcriptional Factor MafA in CD34(+) Cells. Mol Ther Nucleic Acids. 2013; 2: e97, doi: 10.1038/mtna.2013.23 PMID: 23736775
24. Voutila J, Saetrom P, Mintz P, Sun G, Alluin J, Rossi JJ, et al. Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells. Mol Ther Nucleic Acids. 2012; 1: e35, doi: 10.1038/mtna.2012.20 PMID: 23344177
25. Yamamoto K, Tateishi K, Kudo Y, Sato T, Yamamoto S, Miyabayashi K, et al. Loss of histone demethy-lase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPalpha. Carcinogenesis. 2014; 35(11): 2404-2414. doi: 10.1093/carcin/bgu136 PMID: 24947179
26. Banerjee P, Dutta S, Pal R. Dysregulation of Wnt-signaling and a candidate set of miRNAs underlie the effect of metformin on neural crest cell development. Stem Cells. 2016; 34(2): 334-345. doi: 10.1002/stem.2245 PMID: 26529121
27. Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed? Curr Pharm Des. 2015; 21 (10): 1249-1255. PMID: 25506899
28. Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. 2012; 31(3-4): 469-478. doi: 10.1007/s10555-012-9377-5 PMID: 22729277
29. Cicchini C, Amicone L, Alonzi T, Marchetti A, Mancone C, Tripodi M. Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte. Liver Int. 2015; 35(2): 302-310. doi: 10.1111/liv.12577 PMID: 24766136
30. Ye LY, Chen W, Bai XL, Xu XY, Zhang Q, Xia XF, et al. Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis. Cancer Res. 2016; 76(4): 818-830. doi: 10.1158/0008-5472.CAN-15-0977 PMID: 26837767
31. Higashikawa K, Yoneda S, Tobiume K, Taki M, Shigeishi H, Kamata N. Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma. Cancer Res. 2007; 67(19): 9207-9213. PMID: 17909026
32. Huang L, Fu L. Mechanisms of resistance to EGFR tyrosine kinase inhibitors. Acta Pharm Sin B. 2015; 5(5): 390-401. doi: 10.1016/j.apsb.2015.07.001 PMID: 26579470
33. Lindsey S, Langhans SA. Epidermal growth factor signaling in transformed cells. Int Rev Cell Mol Biol. 2015; 314: 1-41. doi: 10.1016/bs.ircmb.2014.10.001 PMID: 25619714
34. Fan FT, Shen CS, Tao L, Tian C, Liu ZG, Zhu ZJ, et al. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation. Asian Pac J Cancer Prev. 2014; 15(5): 1961-1970. PMID: 24716919
35. Li Y, Zhang X, Polakiewicz RD, Yao TP, Comb MJ. HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem. 2008; 283(19): 12686-12690. doi: 10.1074/jbc.C700185200 PMID: 18356165
36. Cheung CT, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, et al. Cyclin A2 modulates EMTvia beta-catenin and phospholipase C pathways. Carcinogenesis. 2015; 36(8): 914-924. doi: 10.1093/carcin/bgv069 PMID: 25993989
37. Liu W, Kovacevic Z, Peng Z, Jin R, Wang P, Yue F, et al. The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets. Oncotarget. 2015; 6(34): 35522-35541. doi: 10.18632/oncotarget.5849 PMID: 26431493
38. Yanaka Y, Muramatsu T, Uetake H, Kozaki K, Inazawa J. miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis. 2015; 36 (11): 1363-1371. doi: 10.1093/carcin/bgv106 PMID: 26264654
39. Hahn S, Jackstadt R, Siemens H, Hunten S, Hermeking H. SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J. 2013; 32(23): 3079-3095. doi: 10.1038/emboj.2013.236 PMID: 24185900